Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-26-037580

CEO and President gave up 141 shares (to pay taxes)

  • CEO and President acquired 577 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KLEMP WALTER V · CEO and President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Exercise or conversion : show line 1 in the form +577 36,686 D
2026-11-16 Shares withheld for taxes : show line 2 in the form −141 $7.41 $1,045 36,545 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2026-11-16 Exercise or conversion : show line 3 in the form Restricted Stock Units −577 577 126,838 D
Loading xslF345X06/rdgdoc.xml…